RCA vessel classification correct
96 percent
- EndpointCorrect vessel classification for RCA
- PopulationRegulatory QFR image-analysis validation cases
- Tested versionQFR 3.0 configuration described in K243769
FDA-cleared profile
QFR Solutions bv · Fluoroscopy/Angiography · FDA-cleared (510(k))
Authorized purpose: QFR (3.0) uses paired coronary X-ray angiographic DICOM acquisitions to calculate three-dimensional vessel and lesion measurements and pressure-drop quantification for interventional cardiologist or researcher review in patients with coronary artery disease.
Overview status: Source-reviewed overview
Workflow role has not yet been reviewed for this navigation pilot.
A tag identifies a documented role; it does not establish compatibility or local acceptance. Methods and sources
Clinical takeaway. Clinical role: QFR (3.0) uses paired coronary X-ray angiographic DICOM acquisitions to calculate three-dimensional vessel and lesion measurements and pressure-drop quantification for interventional cardiologist or researcher review in patients with coronary artery disease.
Evidence takeaway. Evidence from the reviewed source record: K243769 FDA evidence is a regulatory image-analysis validation for QFR 3.0; no independent paper or trial was promoted in this timeboxed review.
Evidence context not reviewed for this FDA record.
Label constraints have not been reviewed for this exact FDA record. Unknown is not all ages or evidence of unsuitability.
Public-label constraints, not patient-level eligibility or a medical recommendation. Training and evaluation populations are separate. Read the original labeling and confirm the exact release and protocol.
Evidence
Metrics are shown only when they are tied to a source, endpoint, population, and tested product version. Candidate literature without exact product and version linkage is not shown as product evidence.
This field has not been curated yet.
This field has not been curated yet.
96 percent
88 percent
78 percent
77 percent
K243769
Manufacturer-submitted FDA evidence; it is not an independent clinical-outcome study.
Safety and lifecycle
Recall and adverse-event records are shown only after product matching. Adverse-event reports do not establish incidence or causality.
Price not public here; enter your quote
Not publicly available: Reviewed sources do not publish an exact-product procurement price with a stated offer scope.
Match the AI release, system build, configuration and region. Source documentation does not establish acceptance of an installed system.
No specific system/version pairing has completed review for this FDA record. A broad DICOM or product-family statement does not establish a named viewer build's support.
Public source context, not tested interoperability. Each hop needs its own release/configuration evidence. Missing or unavailable routes are not documented incompatibility. All local tests are planned, not passed; no installed-system acceptance is recorded.
Acquisition/source → routing → AI processing → returned objects → viewer/worklist/report → support owner
No specific route context has been source-reviewed for this record. Obtain both endpoint builds and documents; this is not a finding of incompatibility.
Source context, not route validation: Coronary X-ray angiography DICOM acquisitions from a monoplane or biplane system, with two suitable projections separated by at least 25 degrees and adequate calibration and image quality.
Scope: Exact FDA submission.
Confirm scanner/model, protocol, series completeness and both software builds.
Field checked 2026-09-07 · FDA 510(k) K243769: QFR (3.0)
Source context, not route validation: The exact software imports coronary XA DICOM studies and can exchange studies and reports with PACS through DICOM services; local modality, PACS, worklist, export, and report routing require acceptance testing.
Scope: Exact FDA submission.
Name gateways, destinations, transfer rules and failure visibility; a DICOM statement does not prove a route.
Field checked 2026-09-07 · FDA 510(k) K243769: QFR (3.0)
Source context, not route validation: The exact FDA packet and QFR manual describe a server installed in the organization network or cathlab/hospital server room, accessed through a web browser; the manual states the QFR server is not cloud or internet hosted for the reviewed version.
Scope: Exact FDA submission.
Confirm processing location, queue ownership, exclusions and exact AI build.
Field checked 2026-09-07 · FDA 510(k) K243769: QFR (3.0) · QFR 3.0 User Manual, FDA version
Source context, not route validation: Three-dimensional reconstructed coronary vessels, vessel and lesion dimensions, quantitative flow ratio/pressure-drop values, analysis snapshots, and a report containing patient, acquisition, and analysis information.
Scope: Exact FDA submission.
Confirm object classes, units, references and whether findings, overlays or measurements reach their intended destination.
Field checked 2026-09-07 · FDA 510(k) K243769: QFR (3.0)
Unresolved route: Three-dimensional reconstructed coronary vessels, vessel and lesion dimensions, quantitative flow ratio/pressure-drop values, analysis snapshots, and a report containing patient, acquisition, and analysis information.
Scope: Exact FDA submission.
Confirm the named viewer/worklist/report build, display behavior and report transfer. Output support alone does not establish this endpoint. The displayed source describes output, not validated end-to-end delivery.
Field checked 2026-09-07 · FDA 510(k) K243769: QFR (3.0)
Unresolved route: Not established for the exact route.
Scope: Scope not established.
Name the local, platform and AI supplier support owners and escalation path.
No tests below have been performed or accepted.
Agree the evidence and acceptance owner with your team and suppliers. Checkmarks apply to this page only and are not acceptance receipts.
Buyer acceptance guidance derived from the exact FDA workflow and manual; it is not a claimed vendor monitoring service.
The QFR manual places the QFR server in the organization network and states it is not cloud or internet hosted for the reviewed version; access is through a web browser and local DICOM connections must be configured.
product family · checked 2026-09-07Manual version 3.0.36.6 was reviewed; confirm that the installed K243769 release has the same deployment behavior.
The manual documents DICOM connection administration, PACS export, audit trail, user roles, and report archiving when configured; test modality import, projection selection, export, report delivery, and failure recovery locally.
product family · checked 2026-09-07The reviewed manual requires XA studies with grayscale square pixels, fixed angulation, calibration, at least five frames, and two projections with at least 25 degrees between angles; invalid or incomplete acquisitions may block or distort analysis.
product family · checked 2026-09-07Regulatory identity
The FDA listing establishes the regulatory identity. It does not by itself establish local workflow fit, pricing, security, or performance in your environment.
Research record
This audit distinguishes completed source review from fields that have not yet been researched.
The stored PubMed and ClinicalTrials.gov candidate arrays were screened and were empty. No paper or trial was promoted; empty stored arrays do not establish that no external literature or trials exist. The current discovery snapshot contains 0 PubMed and 0 ClinicalTrials.gov candidate records; its dated, count-matched human screening remains current. Unlinked candidates remain quarantined. Native FDA recall identifiers produced 0 postmarket candidate records; 0 have been reviewed (0 published, 0 rejected) and 0 remain unreviewed.
Candidate leads were screened against the exact product and tested version. Unlinked records remain quarantined.
Source classes: fda ai list, fda decision summary, acr ai central product, vendor documentation, fda device recall, literature index, trial registry, stored candidate metadata, pubmed, clinical trials, openfda device recall
Recorded state, verification date, notes and sources for fields without a publishable value. Conflicting records stay explicitly unsettled here; no plain settled value is shown for them.
No public list price or contract unit for the exact K243769 configuration was established in the reviewed official sources.
Bounded web search on 2026-10-26 (query: "QFR Solutions reimbursement CPT"; top results reviewed) found no vendor or payer page stating coding, coverage or payment for this product. This records what was found, not that none exists; eligibility depends on payer, site of service and use case.
The reviewed packet and manual describe local deployment, user roles, and audit-trail functions but do not establish a current scoped security attestation, encryption configuration, retention, vulnerability management, or incident response for the installed K243769 release.
8 sources - 3 history items
Scope: identity, clinicalUse, modality, anatomy, intendedUsers, careSetting, workflowRole, input, output, limitations, integration, deployment, evidenceMetrics, evidenceStudies
Scope: regulatoryIdentity, modalityContext
Scope: intendedUsers, careSetting, output, integration, anatomy, implementationCapabilities
Scope: evidenceDiscovery
Scope: evidenceDiscovery, studyStatus
Scope: recallDiscovery, nativeSubmissionMatching
Scope: productFamily, implementationCapabilities, limitations
Scope: postmarketSafety
Regulatory record
510(k)
Research record
human reviewed
Editorial review
Source-reviewed editorial overlay
Alternatives
Cara Medical, Ltd.
Authorized purpose: CARA assists adult structural-heart and conduction-system procedure planning by segmenting preprocedural CT, visualizing cardiac chambers and conduction landmarks, and overlaying a reviewed three-dimensional roadmap on live fluoroscopy.
Caranx Medical
Authorized purpose: TAVIPILOT detects, tracks, and marks the non-coronary cusp and prosthetic valve on live fluoroscopy during specified adult femoral TAVR or TAVI procedures under physician control.
Keya Medical Technology Co., Ltd.
Authorized purpose: Coronary plaque and stenosis quantification from CCTA
Shimadzu Corporation
Authorized purpose: Trinias is an interventional fluoroscopic X-ray system for diagnostic and interventional angiography, including cardiac, neurovascular, abdominal, peripheral, rotational, multipurpose, and whole-body radiographic or fluoroscopic procedures.
Copy this public context and add the field, proposed wording and original source before sending. Nothing here is submitted automatically. Form-specific prefill has not been verified.
Open existing correction destinationPermission to display a submission is not evidence verification. A submission enters editorial review; it does not approve a public change. Form availability, data entry, receipt, review and publication are separate steps. Data entry and receipt remain unverified.
No entry has been added to this scoped change history for this record. This is not proof that the record never changed.
Correction policy and limits · Public repository change history